ID   U-1996
AC   CVCL_M495
DR   Wikidata; Q54973537
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3580570;
RX   PubMed=10936422;
CC   Characteristics: Produces Ig kappa.
CC   Doubling time: 48 hours (PubMed=3580570).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund H., Nilsson K.;
RT   "Multiple myeloma cell lines.";
RL   (In) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters J.R.W., Palsson B.O. (eds.); pp.81-155; Kluwer Academic Publishers; New York (2000).
//
RX   PubMed=3580570; DOI=10.1182/blood.V69.6.1605.1605;
RA   Jernberg H., Nilsson K., Zech L., Lutz D., Nowotny H., Scheirer W.;
RT   "Establishment and phenotypic characterization of three new human
RT   myeloma cell lines (U-1957, U-1958, and U-1996).";
RL   Blood 69:1605-1612(1987).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//